DocGo Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
DocGo Inc. (DCGO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $3.59 per share for the 12-month period ending 2024-12-31, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-11-10
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-31 was $3.66, a 48.81% decline year-over-year.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $7.15, a 0.00% change year-over-year.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $7.15.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $7.93, a 12.64% increase from fiscal 2022.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $7.04, a 144.44% increase from fiscal 2021.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $2.88, a 569.77% increase from fiscal 2020.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $0.43.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $3.59 10-Q · filed 2025-11-10 | ||||
| 2024-09-30 | $2.54 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | $2.54 10-Q · filed 2024-08-07 | ||||
| 2024-03-31 | $3.66 10-Q · filed 2024-05-08 | ||||
| 2023-12-31 | $7.93 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $8.92 10-Q · filed 2023-11-06 | ||||
| 2023-06-30 | $8.61 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | $7.15 10-Q · filed 2023-05-09 | ||||
| 2022-12-31 | $7.04 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | $5.92 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | $7.15 10-Q · filed 2022-08-09 | ||||
| 2022-03-31 | $7.15 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | $2.88 10-K · filed 2023-03-14 | $2.80 10-K · filed 2022-03-15 | |||
| 2020-12-31 | $0.43 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |